Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

A number of people had problems with buying into last week's Euro-zone deal as a panecea for the problems ailing the common currency. Their concerns were mostly centered on the lack of details about how the bank recapitalizations would take place and how the rescue fund (EFSF) would get strengthened.


But those objections now seem almost trivial following the surprise announcement by the Greek government to hold a referendum on the issue. This announcement has overtaken last week's deal and effectively ensures that global markets will remain hostage to electioneering in Greece at least through January, which is the earliest that a referendum could take place.


I would love to read the immediate (private) reactions to the Greek announcement of the German chancellor Angela Merkel and French president Nikolas Sarkozy -- aka "Merkozy." I am not sure how colorful the French and German languages are. But I can bet that their immediate reactions would make for interesting reading if ever made public.


With the Euro-zone deal turning out to be no more enduring than Kim Kardashian's wedding, we are back to square one on the European question. Everything else takes a backseat.


We will likely need an impressive showing from the October manufacturing ISM report coming out a little later to get our minds off the Greek shock. But that is unlikely given Monday's relatively soft Chicago PMI reading. The Fed starts its two-day meeting today as well, but few surprises are expected on that front. Other than Bernanke's press conference Wednesday afternoon, the Fed meeting may be a non-event.


On the earnings front, we had a solid earnings and revenue beat and positive guidance from Pfizer (PFE - Analyst Report). Archer Daniels Midland (ADM - Analyst Report) came short of expectations as high feedstock costs weighed on margins. Baker Hughes (BHI - Analyst Report) also came modestly short of earnings expectations on in-line revenue.


if the market's behavior over the last few months is any guide, then we can say with a lot of confidence that the Greek news supersedes everything else. Reading "Merkozy's" reaction to the Greek announcement would have provided some relief, but unfortunately we may never see those choice words.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GRP IN DXYN 15.84 +7.90%
BOFI HLDG IN BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%